Skip to content

TaskUs TASK Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Meta Platforms, Inc. logo
Meta Platforms, Inc.META
-$271M+87.9%
Genpact logo
GenpactG
-$148.81M-6.1%
Accenture logo
AccentureACN
$967.46M+49.6%
Freshworks, Inc. logo
Freshworks, Inc.FRSH
-$3.44M-594%
Telos Corporation logo
Telos CorporationTLS
-$533K-242%
Insight Enterprises logo
Insight EnterprisesNSIT
$402.42M+2,914%

Other financials

Income statement

See full
Revenue$306.3M+10.3%
Gross profit$108.5M+1.7%
Operating income$34.2M-0.1%
Net income$24.3M+15.1%
EPS (diluted)$0.26+13.0%

Balance sheet

See full
Cash & equivalents$152.3M-22.7%
Total debt$548.0M+79.0%
Total equity$275.0M-47.2%
Total assets$981.6M-0.4%

Cash flow

See full
Operating cash flow$46.3M+27.6%
CapEx$10.2M-29.5%
Free cash flow$36.1M+65.6%

Valuation

See full
Market cap$418.51M-71.7%
Enterprise value$814.21M-48.8%
P/E-22.8×
P/S0.4×-1.1×

Profitability

See full
Gross margin37%-1.9pp
Operating margin11.6%+1.7pp
Net margin8.7%+3.4pp
FCF margin7.3%+0.2pp

Returns & leverage

See full
Return on equity26.5%+15.2pp
Debt / equity+1.4×
Current ratio2.8×-0.1×

Where this comes from

Reported directly by TaskUs in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities.

The official record: TaskUs’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about TaskUs's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TaskUs's change in accrued liabilities?
TaskUs (TASK) reported change in accrued liabilities of -$5.11M in Q1 2026.
How has TaskUs's change in accrued liabilities changed year-over-year?
TaskUs's change in accrued liabilities decreased by 38.3% year-over-year, from -$3.7M to -$5.11M.
What does change in accrued liabilities mean?
Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.